Close

UPDATE: Goldman Sachs Downgrades Intra-Cellular Therapies (ITCI) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA


Go back to UPDATE: Goldman Sachs Downgrades Intra-Cellular Therapies (ITCI) to Neutral
INTRA-CELL THRP (NASDAQ: ITCI) Delayed: 74.01 -0.53 (0.71%)
Previous Close $74.54    52 Week High $59.96 
Open $75.06    52 Week Low $10.80 
Day High $76.89    P/E N/A 
Day Low $73.69    EPS $0.00 
Volume 826,595